Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

AstraZeneca
ClinicalTrials.gov · Datasets · License: Public Domain
Open Source ↗
atherosclerosiscoronary-heart-diseasediabetes-mellitus
hyperlipidemias, atherosclerosis, coronary heart disease, carotid stenosis, peripheral vascular diseases, diabetes mellitus
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 279661
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.